News
March 4, 2026
A new report shows Ireland’s pharmaceutical sector is of unprecedented economic importance and national strategic value. Conclusion of IPHA Framework Agreement is a new direction […]
January 20, 2026
New four-year deal designed to deliver faster patient access to innovative medicines, within 180 days to HSE decisions on reimbursement and a stable policy framework. […]
October 8, 2025
6,000 patients could benefit from €30 million for new medicines announced in Budget 2026 Minister’s commitment to adhering to the legislative timelines for new medicines decisions […]
September 29, 2025
IPHA welcomes the confirmation today (Tuesday 29th September) from the Minister for Health, Jennifer Carroll MacNeill TD, that the State will enter into formal talks on […]
August 21, 2025
Thursday 21st August 2025 IPHA notes the joint statement by the US and EU on tariffs today (Thursday), particularly the aspects dealing with pharmaceuticals. Some mitigation […]
May 7, 2025
Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.
April 23, 2025
The objective of Directive 91/271/EEC is to protect the environment from being adversely affected byinsufficiently treated urban wastewater discharges.
February 26, 2025
Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.
October 21, 2024
Let’s give every patient in Ireland the chance to create new memories. Pfizer, Novo Nordisk, Roche and AbbVie feature in IPHA’s campaign which highlights how, […]